Ifp Advisors, Inc Ocugen, Inc. Transaction History

Ifp Advisors, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$0.82 - $1.33 $187 - $304	-229 Reduced 29.21%	555 $0
Q4 2022 Feb 07, 2023	SELL	$1.11 - $1.87 $311 - $525	-281 Reduced 26.38%	784 $5,000
Q3 2022 Nov 08, 2022	BUY	$1.75 - $3.1 $43 - $77	25 Added 2.4%	1,065 $5,000
Q2 2022 Sep 06, 2022	BUY	$1.83 - $3.45 $1,903 - $3,588	1,040 New	1,040 $4,000
Q2 2022 Aug 12, 2022	SELL	$1.83 - $3.45 $1,903 - $3,588	-1,040 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$2.34 - $4.72 $1,134 - $2,289	485 Added 87.39%	1,040 $3,000
Q2 2021 Jul 13, 2021	SELL	$5.52 - $15.68 $3,173 - $9,016	-575 Reduced 50.88%	555 $4,000
Q1 2021 Apr 30, 2021	BUY	$1.66 - $15.81 $622 - $5,928	375 Added 49.67%	1,130 $8,000
Q4 2020 Jan 25, 2021	BUY	$0.28 - $2.6 $211 - $1,963	755 New	755 $1,000
Q3 2020 Oct 29, 2020	BUY	$0.2 - $0.72 $0 - $0	0 New	0 $0

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $167M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.